| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |